ScholarIQanswers from OpenAlex
Merck & Co., Inc., Rahway, NJ, USA (United States)
InstitutionResearch output, impact & collaborations
Merck & Co., Inc., Rahway, NJ, USA (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Merck & Co., Inc., Rahway, NJ, USA (United States)?
ScholarIQrecord summary
Merck & Co., Inc., Rahway, NJ, USA (United States) is a research organisation in Rahway, US. OpenAlex records 37,054 works and 7,698,843 citations for it. 11,161 researchers list it as their most recent affiliation.
How many works does Merck & Co., Inc., Rahway, NJ, USA (United States) have?
ScholarIQindexed works
Merck & Co., Inc., Rahway, NJ, USA (United States) has 37,054 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Merck & Co., Inc., Rahway, NJ, USA (United States) have?
ScholarIQcitation count
Merck & Co., Inc., Rahway, NJ, USA (United States) has 7,698,843 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Merck & Co., Inc., Rahway, NJ, USA (United States)?
ScholarIQresearcher count
Merck & Co., Inc., Rahway, NJ, USA (United States) has 11,161 researchers in the ScholarIQ index.
What is the average h-index at Merck & Co., Inc., Rahway, NJ, USA (United States)?
ScholarIQavg h-index
Merck & Co., Inc., Rahway, NJ, USA (United States) has an average h-index of 49 in OpenAlex.
What is the ROR of Merck & Co., Inc., Rahway, NJ, USA (United States)?
ScholarIQror
The ROR for Merck & Co., Inc., Rahway, NJ, USA (United States) is on the source record.
What is the OpenAlex record for Merck & Co., Inc., Rahway, NJ, USA (United States)?
ScholarIQopenalex
The OpenAlex for Merck & Co., Inc., Rahway, NJ, USA (United States) is on the source record.
Who are the most-cited researchers behind Merck & Co., Inc., Rahway, NJ, USA (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Merck & Co., Inc., Rahway, NJ, USA (United States)?
ScholarIQmost cited works
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Melanie A. Leiby, Gregory M. Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R. Brahmer
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang, Bjarne R. Bartlett, Holly Kemberling, Aleksandra Eyring, Andrew D. Skora, Brandon Luber, Nilofer S. Azad, Dan Laheru, Barbara Biedrzycki, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Steven M. Duffy, Richard M. Goldberg, Albert de la Chapelle, Minori Koshiji, Feriyl Bhaijee, Thomas Huebner, Ralph H. Hruban, Laura D. Wood, Nathan Cuka, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Toby C. Cornish, Janis M. Taube, Robert A. Anders, James R. Eshleman, Bert Vogelstein, Luis A. Díaz
Integrated genomic analyses of ovarian carcinoma
Debra Bell, Andrew Berchuck, Michael J. Birrer, Marcin Imieliński, Jeremy Chien, D. W. Cramer, Fanny Dao, Douglas A. Levine, Narciso Olvera, Rajiv Dhir, DiSaia Pj, H Gabra, Pat Glenn, Karen Smith‐McCune, A. K. Godwin, Jenny Gross, Beth Y. Karlan, Sandra Oršulić, L Hartmann, Mei Huang, David G. Huntsman, Steve E. Kalloger, Mary Iacocca, Brenda Rabeno, G.B. Mills, John N. Weinstein, Carl Morrison, D. Mutch, Kay J. Park, N. Petrelli, J.S. Rader, Branimir I. Šikić, A.K. Sood, D. Bowtell, R. Penny, T. Shelton, Donata Grimm, Michael J Hatfield, Scott Morris, Peggy Yena, Paul Rhodes, Mark E. Sherman, Joseph Paulauskis, Sherri Z. Millis, Joseph R. Testa, Kuo-Ching Chang, CJ Creighton, Huyen Dinh, Jennifer Drummond, Gerald Fowler, Preethi H. Gunaratne, Alicia Hawes, C. Kovar, Lora Lewis, M. B. Morgan, Irene Newsham, Jireh Santibanez, J. G. Reid, Lisa R. Treviño, Yali Wu, M. Wang, Donna M. Muzny, David A. Wheeler, Richard A. Gibbs, Gaddy Getz, Michael S. Lawrence, K. Cibulskis, A. Y. Sivachenko, Douglas Voet, Kristin Ardlie, Eric S. Lander, Matthew Meyerson, Roeland Verhaak, S. L. Carter, C. H. Mermel, Gordon Saksena, Huy Nguyen, R. C. Onofrio, Diana Hubbard, Sumeet Gupta, A. Crenshaw, Alex H. Ramos, A. Sivachenko, Rui Jing, R. W. Park, Mike Noble, L. Chin, Carrie Sougnez, Wendy Winckler, Jennifer Wilkinson, Jennifer Baldwin, R. Nichol, S. Fisher, Theodora Bloom, Tim Fennell, Stacey Gabriel, L. Ding, R. S. Fulton, D.C. Koboldt, Michael D. McLellan
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J. Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa Ho, Martin L. Miller, Natasha Rekhtman, André L. Moreira, Fawzia K. Ibrahim, Cameron Bruggeman, Billel Gasmi, Roberta Zappasodi, Yuka Maeda, Chris Sander, Edward B. Garon, Taha Merghoub, Jedd D. Wolchok, Ton N. Schumacher, Timothy A. Chan
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Roger E. McLendon, D D Bigner, Allan H. Friedman, Erwin G. Van Meir, Gena M. Mastrogianakis, Jeffrey J. Olson, Daniel J. Brat, Tom Mikkelsen, Norman L. Lehman, Ken Aldape, W.K. Alfred Yung, Oliver Bögler, Scott Vandenberg, Mitchel S. Berger, Michael D. Prados, Donna M. Muzny, Margaret Morgan, Stephen W. Scherer, Aniko Sabo, Lynn Nazareth, Lora Lewis, Otis Hall, Yiming Zhu, Yanru Ren, Omar Alvi, Jiqiang Yao, Alicia Hawes, Shalini N. Jhangiani, Gerald Fowler, Anthony San Lucas, Christie Kovar, Andrew Cree, Huyen Dinh, Jireh Santibanez, Vandita Joshi, Manuel L. Gonzalez‐Garay, Christopher A. Miller, Aleksandar Milosavljevic, David A. Wheeler, Richard A. Gibbs, L A Donehower, Kristian Cibulskis, Carrie Sougnez, Tim Fennell, Scott Mahan, Jane Wilkinson, Liuda Ziaugra, Robert C. Onofrio, Toby Bloom, Robert Nicol, Kristin Ardlie, Jennifer Baldwin, Stacey Gabriel, Eric S. Lander, Gad Getz, Wendy Winckler, Roel G.W. Verhaak, Michael S. Lawrence, Michael O’Kelly, Jim Robinson, Gabriele Alexe, Rameen Beroukhim, Scott L. Carter, Derek Y. Chiang, Josh Gould, Supriya Gupta, Josh Korn, Craig H. Mermel, Jill P. Mesirov, Stefano Monti, Huy Nguyen, Melissa Parkin, Michael Reich, Nicolas Stransky, Barbara A. Weir, Levi A. Garraway, Todd R. Golub, Matthew Meyerson, Jun Li, Robert S. Fulton, Michael D. McLellan, John Wallis, David E. Larson, Xiaoqi Shi, Rachel M. Abbott, Lucinda Fulton, Ken Chen, Daniel C. Koboldt, Michael C. Wendl, Rick Meyer, Yuzhu Tang, Ling Lin, John R. Osborne, Brian H. Dunford-Shore, Tracie L. Miner, Kim D. Delehaunty, Chris Markovic, G.M. Swift, William Courtney, Craig Pohl
Who collaborates most closely around Merck & Co., Inc., Rahway, NJ, USA (United States)?
ScholarIQco-authorship network
United States
80%
France
10%
Canada
10%
How much of the research on Merck & Co., Inc., Rahway, NJ, USA (United States) is open access?
ScholarIQopen access share
67%OPEN ACCESS